XML 54 R21.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
The authorized shares of the Company consist of an unlimited number of common and preferred shares, both without par value. All proceeds received for issuances of common shares are attributed to common shares on the Company’s consolidated balance sheets.
During the year ended December 31, 2025, the Company issued:
i)190,000 common shares on the exercise of warrants, for gross proceeds of $654. In connection with the warrants exercised, the Company reclassified $144 from additional paid-in capital to share capital.
ii)1,049,476 common shares on the exercise of stock options, for gross proceeds of $1,863. In connection with the stock options exercised, the Company reclassified $801 from additional paid-in capital to common shares.
iii)The Company entered into the capped call transactions (the “Capped Call Transactions” on August 20 and August 22, 2025. The Capped Calls Transaction are generally intended to reduce or offset the potential economic dilution to the common shares upon the conversion of the Company’s Convertible Senior Notes. As the Capped Calls Transactions are considered indexed to the Company’s own equity and are equity classified, they are recorded in shareholders’ equity and are not accounted for as a derivative. The costs of $12,006 incurred in connection with the Capped Calls Transactions were recorded as a reduction to additional paid-in capital. The Capped Calls Transactions are excluded from the calculation of diluted earnings per share, as they would be anti-dilutive under treasury stock method.
During the year ended December 31, 2024, the Company issued:
i)2,564,102 units to Boss in February of 2024, for a private placement at a price of $3.90 per unit for gross proceeds of $10,000.
ii)6,872,143 common shares to extinguish the convertible note with a carrying value of $23,117 in February 2024.
iii)8,781,985 common shares on the exercise of warrants, for gross proceeds of $25,471. In connection with the warrants exercised, the Company reclassified $7,902 from additional paid-in capital to share capital.
iv)2,267,155 common shares on the exercise of stock options, for gross proceeds of $1,760. In connection with the stock options exercised, the Company reclassified $1,919 from additional paid-in capital to common stock.
v)495,765 common shares sold in accordance with the Company’s ATM program for gross proceeds of $2,008.

Share Purchase Warrants
A summary of the status of the Company’s warrants as of December 31, 2025 and 2024, and changes during the years then ended is as follows:
Number of WarrantsWeighted Average Exercise Price (CAD)
Outstanding, December 31, 202331,461,804C$4.04
Granted5003.90 
Exercised(8,781,985)3.97 
Expired(2,746,235)5.95 
Outstanding, December 31, 202419,934,084C$3.81
Exercised(190,000)3.75 
Expired(2,444)3.27 
Outstanding, December 31, 202519,741,640C$3.81
As of December 31, 2025, share purchase warrants outstanding were as follows:
Warrants Outstanding December 31, 2025
Warrant Price Per Share (CAD) Number of
Warrants		Weighted Average
Remaining Life
(years)		Weighted Average
Exercise Price
(CAD)
C$4.053,835,4400.02C$4.05
C$3.7515,906,2000.10C$3.75
Total19,741,6400.12C$3.81